Roche India
- All
- News
- Videos
-
Opinion | Sunak To Biden, No Incumbent Has It Easy This Year - Thanks To Economy
From South Korea and Turkey to the UK and the US, incumbent heads of state in most poll-bound countries are struggling to hold on to power and popularity.
-
Opinion | US Presidential Polls: Trump or Biden, India's Stakes Are Higher Than Ever
Under Joe Biden, ties have seen a consolidation in areas like strategic technology and defence. And while Trump has been variously described as "transactional" and "whimsical", India has successfully navigated a Trump presidency in the past.
-
Opinion: Narasimha Rao Recast Not Just India's Economy, But Foreign Policy Too
If India is able to manoeuvre through rough times today, some credit needs to go to Rao, who set India on this course economically and in terms of foreign policy, with a pair of steady hands.
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
India's Antitrust Regulator Orders Probe Into Swiss Drugmaker Roche
Trastuzumab has been a mainstay of Roche's profit for years and brought in global sales of about $6.7 billion in 2016.
-
Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug
Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.
-
Roche, Glenmark Settle Patent Litigation Over Cancer Drug
Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.
-
Cipla Weighs Legal Options After Patent Ruling by Court
Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.
-
Roger Federer Can Play on For Another 4-5 Years, Says Former Coach Tony Roche
Roger Federer recently guided his national team to their first-ever Davis Cup triumph.
-
Big Pharma pushes for US action against India over patent worries: report
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
-
Opinion | Sunak To Biden, No Incumbent Has It Easy This Year - Thanks To Economy
From South Korea and Turkey to the UK and the US, incumbent heads of state in most poll-bound countries are struggling to hold on to power and popularity.
-
Opinion | US Presidential Polls: Trump or Biden, India's Stakes Are Higher Than Ever
Under Joe Biden, ties have seen a consolidation in areas like strategic technology and defence. And while Trump has been variously described as "transactional" and "whimsical", India has successfully navigated a Trump presidency in the past.
-
Opinion: Narasimha Rao Recast Not Just India's Economy, But Foreign Policy Too
If India is able to manoeuvre through rough times today, some credit needs to go to Rao, who set India on this course economically and in terms of foreign policy, with a pair of steady hands.
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
India's Antitrust Regulator Orders Probe Into Swiss Drugmaker Roche
Trastuzumab has been a mainstay of Roche's profit for years and brought in global sales of about $6.7 billion in 2016.
-
Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug
Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.
-
Roche, Glenmark Settle Patent Litigation Over Cancer Drug
Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.
-
Cipla Weighs Legal Options After Patent Ruling by Court
Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.
-
Roger Federer Can Play on For Another 4-5 Years, Says Former Coach Tony Roche
Roger Federer recently guided his national team to their first-ever Davis Cup triumph.
-
Big Pharma pushes for US action against India over patent worries: report
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
